Feasibility of Assessing Radiation Response With MRI/CT Directed Preoperative Accelerated Partial Breast Irradiation in the Prone Position for Hormone Responsive Early Stage Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02186470

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:16.405202+00:00

Published At

2025-09-22T00:00:00+00:00

Record Updated At

2025-09-22

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Estrogen Receptor-positive Breast Cancer", "Invasive Ductal Breast Carcinoma", "Invasive Ductal Breast Carcinoma With Predominant Intraductal Component", "Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate", "Mucinous Ductal Breast Carcinoma", "Papillary Ductal Breast Carcinoma", "Progesterone Receptor-positive Breast Cancer", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Tubular Ductal Breast Carcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2025-09-22"

protocolSection.identificationModule.nctId

"NCT02186470"

protocolSection.identificationModule.officialTitle

"Feasibility of Assessing Radiation Response With MRI/CT Directed Preoperative Accelerated Partial Breast Irradiation in the Prone Position for Hormone Responsive Early Stage Breast Cancer"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Estrogen Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
• Invasive Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Invasive Ductal Breast Carcinoma With Predominant Intraductal Component (protocolSection.conditionsModule.conditions)
• Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate (protocolSection.conditionsModule.conditions)
• Mucinous Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Papillary Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Progesterone Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IA Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IB Breast Cancer (protocolSection.conditionsModule.conditions)
• Tubular Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.